Literature DB >> 27013315

Infections in critically ill burn patients.

F Hidalgo1, D Mas2, M Rubio3, P Garcia-Hierro4.   

Abstract

Severe burn patients are one subset of critically patients in which the burn injury increases the risk of infection, systemic inflammatory response and sepsis. The infections are usually related to devices and to the burn wound. Most infections, as in other critically ill patients, are preceded by colonization of the digestive tract and the preventative measures include selective digestive decontamination and hygienic measures. Early excision of deep burn wound and appropriate use of topical antimicrobials and dressings are considered of paramount importance in the treatment of burns. Severe burn patients usually have some level of systemic inflammation. The difficulty to differentiate inflammation from sepsis is relevant since therapy differs between patients with and those without sepsis. The delay in prescribing antimicrobials increases morbidity and mortality. Moreover, the widespread use of antibiotics for all such patients is likely to increase antibiotic resistance, and costs. Unfortunately the clinical usefulness of biomarkers for differential diagnosis between inflammation and sepsis has not been yet properly evaluated. Severe burn injury induces physiological response that significantly alters drug pharmacokinetics and pharmacodynamics. These alterations impact antimicrobials distribution and excretion. Nevertheless the current available literature shows that there is a paucity of information to support routine dose recommendations.
Copyright © 2016. Publicado por Elsevier España, S.L.U.

Entities:  

Keywords:  Apósito oclusivo; Burns; Descontaminación digestiva selectiva; Infección; Infection; Occlusive dressing; Quemaduras; Selective digestive decontamination

Mesh:

Substances:

Year:  2016        PMID: 27013315     DOI: 10.1016/j.medin.2016.02.001

Source DB:  PubMed          Journal:  Med Intensiva        ISSN: 0210-5691            Impact factor:   2.491


  9 in total

Review 1.  Management and prevention of drug resistant infections in burn patients.

Authors:  Roohi Vinaik; Dalia Barayan; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Expert Rev Anti Infect Ther       Date:  2019-08-04       Impact factor: 5.091

2.  Comparison of Automated Methods Versus the American Burn Association Sepsis Definition to Identify Sepsis and Sepsis With Organ Dysfunction/Septic Shock in Burn-Injured Adults.

Authors:  Megan A Rech; Michael J Mosier; Susan Zelisko; Giora Netzer; Elizabeth J Kovacs; Majid Afshar
Journal:  J Burn Care Res       Date:  2017 Sep/Oct       Impact factor: 1.845

3.  Early Low Level of Procalcitonin Is Associated with a Favorable Outcome in a Case of a Surviving Patient with 80% Body Surface Area Thermal Burn.

Authors:  Bogdan Pavel; Mihaela Roxana Popescu; Daria Skolozubova; Elena Flutur; Vlad Mihai Voiculescu; Ariana Cristina Brezeanu
Journal:  Am J Case Rep       Date:  2021-11-26

4.  Retrospective analysis of patients with burn injury treated in a burn center in Turkey during the Syrian civil war.

Authors:  Yucel Yuce; Hakan A Acar; Kutlu H Erkal; Nur B Arditi
Journal:  Saudi Med J       Date:  2017-01       Impact factor: 1.484

5.  Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients.

Authors:  Luís Cabral; Vera Afreixo; Rita Meireles; Miguel Vaz; Catarina Chaves; Marisa Caetano; Luís Almeida; José Artur Paiva
Journal:  Burns Trauma       Date:  2018-03-31

6.  Treatment algorithm in 960 pediatric burn cases: A review of etiology and epidemiology.

Authors:  Veli Avci; Omer Faruk Kocak
Journal:  Pak J Med Sci       Date:  2018 Sep-Oct       Impact factor: 1.088

Review 7.  Viral Infections in Burn Patients: A State-Of-The-Art Review.

Authors:  Jacek Baj; Izabela Korona-Głowniak; Grzegorz Buszewicz; Alicja Forma; Monika Sitarz; Grzegorz Teresiński
Journal:  Viruses       Date:  2020-11-17       Impact factor: 5.048

8.  Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran.

Authors:  Bahman Mirzaei; Zahra Norouzi Bazgir; Hamid Reza Goli; Fatemeh Iranpour; Fatemeh Mohammadi; Ryhaneh Babaei
Journal:  BMC Res Notes       Date:  2020-08-10

Review 9.  The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review.

Authors:  Alessandro Lazzaro; Gabriella De Girolamo; Valeria Filippi; Giuseppe Pietro Innocenti; Letizia Santinelli; Giancarlo Ceccarelli; Enrico Maria Trecarichi; Carlo Torti; Claudio Maria Mastroianni; Gabriella d'Ettorre; Alessandro Russo
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.